HIV-1, NFAT, and cyclosporin: Immunosuppression for the immunosuppressed?

DNA and Cell Biology

Volumn 20, Issue 12, 2002, Pages 761-767

  Cron, Randy Q ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLOSPORIN A; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMID DNA; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; DRUG ACTIVITY; DRUG MECHANISM; GENE ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOSPORINE; DNA-BINDING PROTEINS; GENE EXPRESSION; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; TACROLIMUS; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036182813     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454901753438570     Document Type: Article

References (72)

1. AIDS vaccine development
2. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease
3. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT
4. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A
5. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells
6. Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation
7. Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus
8. A controlled trial of cyclosporine in HIV infection
9. Cyclosporine for rectoperineal fistula in a human immunodeficiency virus-infected child
10. Modulation of HIV-enhancer activity by heterologous agents: A minireview
11. 2+, calcineurin, and NF-AT
12. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells
13. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells
14. Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes
15. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: A positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1
16. Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody
17. HIV-1: Fifteen proteins and an RNA
18. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP)
19. Cellular transcription factors involved in the regulation of HIV-1 gene expression
20. Successful long-term use of cyclosporin A in HIV-induced pityriasis lichenoides chronica
21. The molecular biology of the AIDS virus
22. The mechanism of action of cyclosporin A and FK506
23. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children
24. Outcome of HIV infection in transplant patient on cyclosporin
25. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506
26. Treatment of human immunodeficiency virus (HIV)-associated nephropathy
27. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells
28. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells
29. Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product
30. Purification and analysis of bispecific tetrameric antibody complexes
31. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation
32. Long-term follow-up of HIV positive asymptomatic patients having received cyclosporin A
33. Identification of cisacting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1
34. Mechanisms of transactivation by nuclear factor of activated T cells-1
35. Expression of NFAT-family proteins in normal human T cells
36. Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1
37. Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys
38. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp
39. The role of chromatin in HIV-1 transcriptional regulation
40. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
41. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: Involvement of NF-kappaB and NFAT
42. NF-AT components define a family of transcription factors targeted in T-cell activation
43. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity
44. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro
45. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter
46. Cyclosporine-induced deterioration in patients with AIDS
47. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children
48. Transcription factors of the NFAT family: Regulation and function
49. New uses for old drugs in HIV infection: The role of hydroxyurea, cyclosporin and thalidomide
50. Regulation of HIV-1 gene expression by cellular transcription factors
51. HIV chemotherapy
52. Cyclosporin A in combination with HAART in primary HIV-1 infection
53. Regulation of HIV-1 transcription
54. Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation
55. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation: Data on four cases and review of the literature
56. Identification of a putative regulator of early T cell activation genes
57. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes
58. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I
59. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1
60. JNK is involved in signal integration during costimulation of T lymphocytes
61. + T cells requires a cyclosporin A-sensitive pathway
62. Cyclosporins: Immunosuppressive drugs with anti-HIV-1 activity
63. Redundant expression but selective utilization of nuclear factor of activated T cells family members
64. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat
65. Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine
66. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity
67. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells
68. Cell type specificity and activation requirements for NFAT-1 (nuclear factor of activated T-cells) transcriptional activity determined by a new method using transgenic mice to assay transcriptional activity of an individual nuclear factor
69. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice
70. AIDS: Politics of premature French claim of cure
71. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation
72. $1 million study renews HIV/transplant research